- Conditions
- Cystic Fibrosis
- Interventions
- Symdeko, Ivacaftor and Symdeko
- Drug
- Lead sponsor
- University of Alabama at Birmingham
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 1 participant
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2019
- U.S. locations
- 1
- States / cities
- Birmingham, Alabama
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 505–528
of 853
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Premature Infants, Parent-Child Relations
- Interventions
- H-HOPE Intervention
- Behavioral
- Lead sponsor
- Medical College of Wisconsin
- Other
- Eligibility
- Not listed
- Enrollment
- 1,882 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2020 – 2024
- U.S. locations
- 4
- States / cities
- Chicago, Illinois • Park Ridge, Illinois • Durham, North Carolina + 1 more
- Conditions
- Premature Infants
- Interventions
- Not listed
- Lead sponsor
- University of Utah
- Other
- Eligibility
- Up to 7 Days
- Enrollment
- 68 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2002 – 2005
- U.S. locations
- 1
- States / cities
- Salt Lake City, Utah
- Conditions
- Preterm Infant, Early-Onset Neonatal Sepsis, Umbilical Cord
- Interventions
- Placental/Umbilical Cord Blood sample
- Other
- Lead sponsor
- The University of Texas Medical Branch, Galveston
- Other
- Eligibility
- Up to 1 Day
- Enrollment
- 65 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2020
- U.S. locations
- 1
- States / cities
- Galveston, Texas
- Conditions
- Pain, Acute
- Interventions
- Pain Measurement
- Other
- Lead sponsor
- Stanford University
- Other
- Eligibility
- 1 Day to 6 Months
- Enrollment
- 43 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2022
- U.S. locations
- 1
- States / cities
- Palo Alto, California
- Conditions
- Intraventricular Hemorrhage, Hydrocephalus
- Interventions
- Removal of CSF through ventricular access device, Removal of CSF through a ventricular access device
- Procedure
- Lead sponsor
- Washington University School of Medicine
- Other
- Eligibility
- Up to 34 Weeks
- Enrollment
- 7 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2013
- U.S. locations
- 1
- States / cities
- St Louis, Missouri
- Conditions
- Candida Infection, Premature Infant
- Interventions
- Medium-Chain Triglyceride (MCT) Oil
- Drug
- Lead sponsor
- Joseph Bliss
- Other
- Eligibility
- Up to 6 Months
- Enrollment
- 12 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2021
- U.S. locations
- 1
- States / cities
- Providence, Rhode Island
- Conditions
- Respiratory Distress Syndrome, Newborn, Bronchopulmonary Dysplasia
- Interventions
- Noninvasive neurally adjusted ventilatory assist (NIV NAVA), Nasal intermittent positive pressure ventilation (NIPPV)
- Other
- Lead sponsor
- Arkansas Children's Hospital Research Institute
- Other
- Eligibility
- Up to 12 Months
- Enrollment
- 15 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2018
- U.S. locations
- 1
- States / cities
- Little Rock, Arkansas
- Conditions
- Respiratory Syncytial Virus Infections
- Interventions
- MEDI8897, Placebo
- Drug
- Lead sponsor
- AstraZeneca
- Industry
- Eligibility
- 0 Years to 1 Year
- Enrollment
- 3,012 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2019 – 2023
- U.S. locations
- 66
- States / cities
- Birmingham, Alabama • Fort Defiance, Arizona • Fayetteville, Arkansas + 59 more
- Conditions
- Lung Diseases, Respiratory Distress Syndrome, Newborn, Pulmonary Surfactant, Lung Diseases, Interstitial
- Interventions
- Not listed
- Lead sponsor
- Washington University School of Medicine
- Other
- Eligibility
- Up to 1 Year
- Enrollment
- 5,176 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2001 – 2024
- U.S. locations
- 1
- States / cities
- St Louis, Missouri
- Conditions
- Respiratory Distress Syndrome, Newborn, Apnea of Newborn
- Interventions
- NIV plus software
- Device
- Lead sponsor
- Keck School of Medicine of USC
- Other
- Eligibility
- 0 Days to 30 Days
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2024
- U.S. locations
- 1
- States / cities
- Los Angeles, California
- Conditions
- Retinopathy of Prematurity
- Interventions
- Investigational ultracompact OCT and OCTA system, retinal photographs
- Device
- Lead sponsor
- Duke University
- Other
- Eligibility
- Not listed
- Enrollment
- 236 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2021 – 2027
- U.S. locations
- 2
- States / cities
- Durham, North Carolina • Philadelphia, Pennsylvania
- Conditions
- Language Delay, Language Development, Feeding; Difficult, Newborn, Mother-Infant Interaction, Maternal Behavior
- Interventions
- Oromotor stimulation, Reading curriculum, LENA recording, LENA linguistic feedback, No oromotor stimulation
- Behavioral
- Lead sponsor
- Women and Infants Hospital of Rhode Island
- Other
- Eligibility
- 23 Weeks to 30 Weeks
- Enrollment
- 124 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025 – 2030
- U.S. locations
- 1
- States / cities
- Providence, Rhode Island
- Conditions
- Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age, Infant, Premature, Persistent Fetal Circulation Syndrome, Persistent Pulmonary Hypertension of Newborn
- Interventions
- Not listed
- Lead sponsor
- NICHD Neonatal Research Network
- Network
- Eligibility
- Up to 7 Days
- Enrollment
- 385 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 1993 – 1994
- U.S. locations
- 13
- States / cities
- Palo Alto, California • New Haven, Connecticut • Washington D.C., District of Columbia + 10 more
- Conditions
- Respiratory Distress Syndrome, Newborn
- Interventions
- Surfactant administered via Laryngeal Mask Airway (LMA), standard of care (nasal CPAP and supplemental oxygen)
- Device · Other
- Lead sponsor
- University of Virginia
- Other
- Eligibility
- Up to 72 Hours
- Enrollment
- 380 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2009
- U.S. locations
- 1
- States / cities
- Charlottesville, Virginia
- Conditions
- Premature Birth
- Interventions
- Not listed
- Lead sponsor
- University of Utah
- Other
- Eligibility
- 31 Weeks to 42 Weeks
- Enrollment
- 72 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2008 – 2012
- U.S. locations
- 1
- States / cities
- Salt Lake City, Utah
- Conditions
- Hypoxia-Ischemia, Brain, Periventricular Leukomalacia
- Interventions
- Not listed
- Lead sponsor
- Johns Hopkins University
- Other
- Eligibility
- Not listed
- Enrollment
- 4 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2008
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
- Conditions
- Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age, Infant, Premature, Enterocolitis, Necrotizing, Intestinal Perforation
- Interventions
- Not listed
- Lead sponsor
- NICHD Neonatal Research Network
- Network
- Eligibility
- Up to 6 Weeks
- Enrollment
- 156 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2001 – 2004
- U.S. locations
- 17
- States / cities
- Birmingham, Alabama • Palo Alto, California • San Diego, California + 13 more
- Conditions
- Extreme Prematurity, Respiratory Distress Syndrome
- Interventions
- LISA
- Procedure
- Lead sponsor
- University of Texas Southwestern Medical Center
- Other
- Eligibility
- 5 Minutes to 20 Minutes
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2025
- U.S. locations
- 1
- States / cities
- Dallas, Texas
- Conditions
- Necrotizing Enterocolitis
- Interventions
- IBP-9414, Placebo
- Drug
- Lead sponsor
- Infant Bacterial Therapeutics
- Industry
- Eligibility
- Up to 48 Hours
- Enrollment
- 120 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2017
- U.S. locations
- 15
- States / cities
- Little Rock, Arkansas • Los Angeles, California • Gainesville, Florida + 10 more
- Conditions
- Preterm Delivery, Inadequate Milk Production
- Interventions
- Merotocin, Placebo
- Drug
- Lead sponsor
- Ferring Pharmaceuticals
- Industry
- Eligibility
- 18 Years to 44 Years · Female only
- Enrollment
- 4 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2022
- U.S. locations
- 10
- States / cities
- New Haven, Connecticut • South Bend, Indiana • Baltimore, Maryland + 7 more
- Conditions
- Respiratory Distress Syndrome, Newborn, Respiratory Distress Syndrome in Premature Infant
- Interventions
- Lung ultrasound
- Diagnostic Test
- Lead sponsor
- Hackensack Meridian Health
- Other
- Eligibility
- 27 Weeks to 34 Weeks
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2028
- U.S. locations
- 1
- States / cities
- Hackensack, New Jersey
- Conditions
- Prematurity, Neurodevelopmental Disorder, Carnitine Deficiency
- Interventions
- L-carnitine, 5% Dextrose
- Drug
- Lead sponsor
- Montefiore Medical Center
- Other
- Eligibility
- 1 Day to 3 Days
- Enrollment
- 144 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2021
- U.S. locations
- 2
- States / cities
- The Bronx, New York
- Conditions
- Bronchopulmonary Dysplasia
- Interventions
- Alvesco Inhalant Product
- Drug
- Lead sponsor
- Venkatesh Sampath
- Other
- Eligibility
- 8 Days to 35 Days
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 1
- States / cities
- Kansas City, Missouri